LCN2 and inflammatory breast carcinoma: Multivariate analysis showed that LCN2 was expressed significantly higher in IBC tumors relative to non‐IBC tumors, independently from the molecular subtype differences (Odds ratio, 1.71, P = 0.034; Table 2).